Literature DB >> 11313471

DR3 regulates negative selection during thymocyte development.

E C Wang1, A Thern, A Denzel, J Kitson, S N Farrow, M J Owen.   

Abstract

DR3 (Ws1, Apo3, LARD, TRAMP, TNFSFR12) is a member of the death domain-containing tumor necrosis factor receptor (TNFR) superfamily, members of which mediate a variety of developmental events including the regulation of cell proliferation, differentiation, and apoptosis. We have investigated the in vivo role(s) of DR3 by generating mice congenitally deficient in the expression of the DR3 gene. We show that negative selection and anti-CD3-induced apoptosis are significantly impaired in DR3-null mice. In contrast, both superantigen-induced negative selection and positive selection are normal. The pre-T-cell receptor-mediated checkpoint, which is dependent on TNFR signaling, is also unaffected in DR3-deficient mice. These data reveal a nonredundant in vivo role for this TNF receptor family member in the removal of self-reactive T cells in the thymus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313471      PMCID: PMC100267          DOI: 10.1128/MCB.21.10.3451-3461.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  55 in total

1.  FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.

Authors:  A M Chinnaiyan; K O'Rourke; M Tewari; V M Dixit
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

2.  A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain.

Authors:  M P Boldin; E E Varfolomeev; Z Pancer; I L Mett; J H Camonis; D Wallach
Journal:  J Biol Chem       Date:  1995-04-07       Impact factor: 5.157

Review 3.  ICE family proteases: mediators of all apoptotic cell death?

Authors:  P A Henkart
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

4.  Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes.

Authors:  P Kisielow; H Blüthmann; U D Staerz; M Steinmetz; H von Boehmer
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

5.  Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene.

Authors:  A Strasser; A W Harris; H von Boehmer; S Cory
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

6.  TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.

Authors:  H Hsu; H B Shu; M G Pan; D V Goeddel
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

7.  Structure and expression of murine CD30 and its role in cytokine production.

Authors:  M A Bowen; R K Lee; G Miragliotta; S Y Nam; E R Podack
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

Review 8.  ICE-like proteases in apoptosis.

Authors:  S Kumar
Journal:  Trends Biochem Sci       Date:  1995-05       Impact factor: 13.807

9.  Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice.

Authors:  R Amakawa; A Hakem; T M Kundig; T Matsuyama; J J Simard; E Timms; A Wakeham; H W Mittruecker; H Griesser; H Takimoto; R Schmits; A Shahinian; P Ohashi; J M Penninger; T W Mak
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

10.  A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor.

Authors:  M Rothe; S C Wong; W J Henzel; D V Goeddel
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

View more
  46 in total

1.  Conditional Fas-associated death domain protein (FADD): GFP knockout mice reveal FADD is dispensable in thymic development but essential in peripheral T cell homeostasis.

Authors:  Yuhang Zhang; Stephen Rosenberg; Hanming Wang; Hongxia Z Imtiyaz; Ying-Ju Hou; Jianke Zhang
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunity.

Authors:  Jason P Twohig; Morgan Marsden; Simone M Cuff; John R Ferdinand; Awen M Gallimore; William V Perks; Aymen Al-Shamkhani; Ian R Humphreys; Eddie C Y Wang
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

Review 3.  Are we really on the right TRAIL?

Authors:  Erika Cretney; Adam P Uldrich; Stuart P Berzins; Andreas Strasser; Dale I Godfrey; Mark J Smyth
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 4.  A survival guide to early T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  On death receptor 3 and its ligands….

Authors:  Eddie C Y Wang
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

Review 6.  TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.

Authors:  Françoise Meylan; Arianne C Richard; Richard M Siegel
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 7.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 8.  Immunobiology of tumor necrosis factor receptor superfamily.

Authors:  Tong Zhou; John D Mountz; Robert P Kimberly
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

9.  Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease.

Authors:  William V Perks; Ravinder K Singh; Gareth W Jones; Jason P Twohig; Anwen S Williams; Ian R Humphreys; Philip R Taylor; Simon A Jones; Eddie C Y Wang
Journal:  Am J Pathol       Date:  2016-09-21       Impact factor: 4.307

10.  TL1A both promotes and protects from renal inflammation and injury.

Authors:  Rafia S Al-Lamki; Jun Wang; Aviva M Tolkovsky; J Andrew Bradley; Jules L Griffin; Sathia Thiru; Eddie C Y Wang; Eleanor Bolton; Wang Min; Paul Moore; Jordan S Pober; John R Bradley
Journal:  J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.